Wu Xu, Liu Zilong, Chang Su Chi, Fu Cuiping, Li Wenjing, Jiang Hong, Jiang Liyan, Li Shanqun
Department of Pulmonary Medicine, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Clinical Center for Sleep Breathing Disorder and Snoring, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Respir Res. 2016 Feb 16;17:16. doi: 10.1186/s12931-016-0333-8.
Nocturnal heart block often occurs in patients with obstructive sleep apnoea (OSA). It is more likely to be undiagnosed in heart block patients who are ignorant of the symptoms of sleep disorder. Berlin Questionnaire (BQ) is a highly reliable way to discover the risk factors of OSA, whereas the validity in sleep-related heart block patients is uncertain. We performed an observational study to address these issues and confirmed the potential protective effect of continuous positive airway pressure (CPAP).
Patients who were previously diagnosed with nocturnal heart block with R-R pauses exceeding 2 seconds were retrospective screened from the ECG centre of Zhongshan hospital. These recruited participants completed Berlin Questionnaire and underwent polysomnography synchronously with 24-hour Holter monitoring. A cross-sectional analysis was performed to confirm the association between nocturnal arrhythmia and OSA, as well as to assess the diagnostic accuracy of the BQ. Subsequently, subjects diagnosed with OSA (apnoea-hypopnoea index > 5) underwent 3 consecutive days of CPAP therapy. On the third day, patients repeated 24-hour Holter monitoring within the institution of CPAP.
The symptoms of disruptive snoring and hypersomnolence in 72 enrolled patients were more related to the occurrence of nocturnal heart block (r = 0.306, 0.226, respectively, p = 0.015, 0.019) than syncope (r = 0.134, p = 0.282) and palpitations (r = 0.106, p = 0.119), which were prominent trait of our study population. The sensitivity, specificity, positive and negative predictive value of the BQ at a cut-off point of 5 of AHI for detecting OSA in heart block patients was 81.0 %, 44.4 %, 91.07 % and 25 %. Nocturnal heart block does not appear to occur exclusively in severe sleep apnoea. The frequent occurrence of arrhythmias in prominent oxygen desaturation supports the correlation between them. CPAP therapy resulted in significant decrease in the average number of episodes of heart block, from 148.58 ± 379.44 to 16.07 ± 58.52 (p < 0.05), same to the change of the longest RR pausing time (from 4.38 ± 2.95 s to 0.57 ± 1.05 s, p = 0.169) in 51 patients. The optimal therapy pressure to make the observed arrhythmia disappeared is 12 cm H2O.
Concerning high prevalence of OSA in heart block patients, BQ provided an economical and efficient screening method for OSA. For better management, CPAP therapy is feasible to prevent heart blocks avoiding unnecessary concomitant pacemaker implantation.
夜间心脏传导阻滞常发生于阻塞性睡眠呼吸暂停(OSA)患者。在不了解睡眠障碍症状的心脏传导阻滞患者中,这种情况更易被漏诊。柏林问卷(BQ)是发现OSA危险因素的一种高度可靠的方法,但其在与睡眠相关的心脏传导阻滞患者中的有效性尚不确定。我们进行了一项观察性研究以解决这些问题,并证实了持续气道正压通气(CPAP)的潜在保护作用。
从中山医院心电图中心回顾性筛选出先前诊断为夜间心脏传导阻滞且R-R间期超过2秒的患者。这些招募的参与者完成柏林问卷,并同步进行多导睡眠图检查和24小时动态心电图监测。进行横断面分析以确认夜间心律失常与OSA之间的关联,并评估BQ的诊断准确性。随后,诊断为OSA(呼吸暂停低通气指数>5)的受试者接受连续3天的CPAP治疗。在第三天,患者在CPAP治疗机构内重复进行24小时动态心电图监测。
72例入组患者中,打鼾和嗜睡症状与夜间心脏传导阻滞的发生相关性更强(分别为r = 0.306、0.226,p = 0.015、0.019),而晕厥(r = 0.134,p = 0.282)和心悸(r = 0.106,p = 0.119)与之相关性较弱,这是我们研究人群的突出特征。在心脏传导阻滞患者中,当AHI截断值为5时,BQ检测OSA的敏感性、特异性、阳性预测值和阴性预测值分别为81.0%、44.4%、91.07%和25%。夜间心脏传导阻滞似乎并非仅发生于严重睡眠呼吸暂停患者。明显的氧饱和度下降时心律失常频繁发生支持了两者之间的相关性。CPAP治疗使心脏传导阻滞发作的平均次数显著减少,从148.58±379.44次降至16.07±58.52次(p<0.05),51例患者的最长RR间期也有同样变化(从4.38±2.95秒降至0.57±1.05秒,p = 0.169)。使观察到的心律失常消失的最佳治疗压力为12 cm H2O。
鉴于心脏传导阻滞患者中OSA的高患病率,BQ为OSA提供了一种经济有效的筛查方法。为了更好地管理,CPAP治疗对于预防心脏传导阻滞是可行的,可避免不必要的起搏器植入。